Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR   3:59:51 PM EDT
66.06
+0.21 (+0.32%)
Earnings Announcements

Arrowhead Earns $10 Million Phase 1 Milestone Payment

Published: 09/28/2021 11:46 GMT
Arrowhead Pharmaceuticals Inc. (ARWR) - Arrowhead Earns $10 Million Phase 1 Milestone Payment.
Arrowhead Pharmaceuticals Inc - Earned a $10 Million Milestone Payment From Janssen Pharmaceuticals, Inc.arrowhead Pharmaceuticals Inc - Milestone Payment Earned After Janssen Dosed Fifth Patient in a Phase 1 Clinical Study of Aro-jnj1.
Revenue is expected to be $42.19 Million
Adjusted EPS is expected to be $0.05

Next Quarter Revenue Guidance is expected to be $22.53 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.